Cargando…
Efficacy and Safety of Low-Dose Cyclosporine Relative to Immunomodulatory Drugs Used in Atopic Dermatitis: A Systematic Review and Meta-Analysis
Cyclosporine A (CsA) is effective in treating moderate-to-severe atopic dermatitis (AD). This systematic review and meta-analysis aimed to summarize the effectiveness and safety of low-dose (<4 mg/kg) versus high-dose (≥4 mg/kg) CsA and other systemic immunomodulatory agents in patients with AD....
Autores principales: | Kim, Kyunghoon, Kim, Mina, Rhee, EunHee, Lee, Mi-Hee, Yang, Hyeon-Jong, Park, Suyeon, Kim, Hwan Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959975/ https://www.ncbi.nlm.nih.gov/pubmed/36835928 http://dx.doi.org/10.3390/jcm12041390 |
Ejemplares similares
-
Effect of Vitamin D on the Treatment of Atopic Dermatitis With Consideration of Heterogeneities: Meta-Analysis of Randomized Controlled Trials
por: Park, Ji Soo, et al.
Publicado: (2022) -
Treatment of Severe Atopic Dermatitis with a Combination of Subcutaneous Allergen Immunotherapy and Cyclosporin
por: Nahm, Dong-Ho, et al.
Publicado: (2012) -
Addressing topical corticosteroid phobia in atopic dermatitis: The
role of the pharmacist
por: Ladda, Matthew, et al.
Publicado: (2021) -
Cyclosporine Improves Sleep Quality in Patients with Atopic Dermatitis
por: Yasuda, Ken-ichi, et al.
Publicado: (2020) -
Immunomodulatory and Anti-inflammatory Effects of Asiatic Acid in a DNCB-Induced Atopic Dermatitis Animal Model
por: Moon, Gyo-Ha, et al.
Publicado: (2021)